71 – 80 of 125
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
- Contribution to journal › Article
- 2007
-
Mark
Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.
- Contribution to journal › Article
-
Mark
A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer
- Contribution to journal › Article
-
Mark
Active surveillance vs radical prostatectomy.
- Contribution to journal › Article
-
Mark
The continuing role of PSA in the detection and management of prostate cancer
- Contribution to journal › Article
-
Mark
Adjuvant radiotherapy after radical prostatectomy
- Contribution to journal › Article
- 2006
-
Mark
Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer
- Contribution to journal › Article
-
Mark
Hormone therapy: Improving therapy decisions and monitoring
- Contribution to journal › Article
-
Mark
Advances in Biomarkers for Prostate Diseases
(2006) p.85-85
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Interview with Professor Per-Anders Abrahamson: Angiogenesis and renal cell carcinoma
- Contribution to journal › Debate/Note/Editorial
